Amgen
AMGN
2,217 hedge funds and large institutions have $109B invested in Amgen in 2021 Q1 according to their latest regulatory filings, with 146 funds opening new positions, 921 increasing their positions, 846 reducing their positions, and 125 closing their positions.
17% more first-time investments, than exits
New positions opened: 146 | Existing positions closed: 125
8% more capital invested
Capital invested by funds: $101B → $109B (+$8.29B)
2% more funds holding in top 10
Funds holding in top 10: 52 → 53 (+1)
9% more repeat investments, than reductions
Existing positions increased: 921 | Existing positions reduced: 846
0.65% more ownership
Funds ownership: 75.45% → 76.1% (+0.65%)
0% less funds holding
Funds holding: 2,220 → 2,217 (-3)
4% less call options, than puts
Call options by funds: $1.03B | Put options by funds: $1.07B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Charles Schwab
San Francisco,
California
|
+$857M |
| 2 |
Fidelity International
Hamilton,
Bermuda
|
+$263M |
| 3 |
Franklin Resources
San Mateo,
California
|
+$262M |
| 4 |
BlackRock
New York
|
+$231M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$210M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$606M |
| 2 |
Canada Life
Winnipeg,
Manitoba, Canada
|
-$145M |
| 3 |
Nuveen
Charlotte,
North Carolina
|
-$105M |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$99.3M |
| 5 |
State Street
Boston,
Massachusetts
|
-$95.5M |
AMGN Hedge Fund Activity: Q1 2021 in Review
2,217 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in Amgen (AMGN) for Q1 2021, worth a combined $109B — up 8.2% from $101B a quarter earlier.
Buyers outnumbered sellers: 146 funds opened new AMGN positions and 125 closed out — a net gain of 21 holders — while 921 added to existing stakes and 846 trimmed.
The largest buyer was Charles Schwab, adding an estimated $857M. The largest seller was Fidelity Investments, cutting an estimated $606M.
- 2,217 institutional investors held Amgen (AMGN) as of Q1 2021, down from 2,220 in Q4 2020.
- Funds reported $109B of Amgen stock for Q1 2021, up 8.2% quarter-over-quarter.
- 146 funds opened new Amgen positions in Q1 2021 and 125 closed out, a net change of +21 holders.
- The largest Amgen buyer in Q1 2021 was Charles Schwab, an estimated $857M added.
- The largest Amgen seller in Q1 2021 was Fidelity Investments, an estimated $606M sold.
Based on aggregated 13F filings for Q1 2021.